BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
BioPharm Executive - Golden Handshakes
MedImmune (AZN), MD Anderson Cancer Center Agree To Launch Moon Shot At Cancer 3/20/2014  More...
Five Prime Therapeutics, Inc. (FPRX), Bristol-Myers Squibb Company (BMY) Strike $350 Million Immuno-Oncology Pact 3/18/2014  More...
Charles River Laboratories (Massachusetts) Shells Out $179 Million Cash To Buy Galapagos NV (GLPG.BR)'s CRO Services Division 3/13/2014  More...
Top Biopharmas Such As Abbott Laboratories (ABT) And GlaxoSmithKline (GSK) Still Betting On "Messed Up" Indian Drugs Market 3/12/2014  More...
Novartis AG (NVS) Chairman Rules Out Merger With Roche (RHHBY) 3/3/2014  More...
Actavis (ACT) Bags Rival, Forest Laboratories, Inc. (FRX), For $25 Billion; Forest Stock Rockets +27.52% At Market Close (February 18, 2014) 2/19/2014  More...
CoStim Pharmaceutical Buyout Bolsters Novartis AG (NVS)'s Cancer Portfolio 2/18/2014  More...
Mallinckrodt Pharmaceuticals (MNK) Adds Pain Drug With $1.3 Billion Cash Cadence Pharmaceuticals, Inc. Buyout 2/11/2014  More...
Eli Lilly and Company (LLY), Pfizer Inc. (PFE) And Eight Other Rivals Join The National Institutes of Health (NIH) In $230 Million Deal To Search For New Drugs 2/5/2014  More...
Ablynx (ABLYF), Merck & Co., Inc. (MRK) Forge Cancer Pact Worth $2.3 Billion 2/3/2014  More...
Nantbioscience Scores $75 Million Cancer Deal With Celgene Corporation (CELG) 1/16/2014  More...
Regeneron Pharmaceuticals, Inc. (REGN), Bayer HealthCare (BAY) Forge Pact Worth $65 Million+ To Co-develop Wet AMD Drug 1/14/2014  More...
Jazz Pharmaceuticals plc (JAZZ) Forges Pact Worth $397 Million For Aerial BioPharma's Sleepiness Drug 1/13/2014  More...
Santaris Pharma A/S, Roche (RHHBY) Strike $148 Million+ Alliance To Design And Develop RNA-Targeted Drugs 1/10/2014  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) May Pay Sangamo BioSciences, Inc. (SGMO) As Much As $320 Million For Blood Drugs; SGMA Soars +38.32% At Market Close (January 9, 2014) 1/9/2014  More...
Roche (RHHBY) Inks Deal Worth Up To $600 Million For Prothena Corporation plc's Parkinson's Drug 12/13/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB), Proteostasis Therapeutics, Inc. Hammer Out $200 Million+ Pre-Clinical Alzheimer's Pact 12/9/2013  More...
AstraZeneca PLC (AZN) Said To Be Eyeing Forest Laboratories, Inc. (FRX) Takeover Bid 12/4/2013  More...
Roche (RHHBY), Molecular Partners AG Ink $1 Billion+ Cancer Pact 12/4/2013  More...
Celgene Corporation (CELG) Smacks Down $177 Million Upfront For OncoMed Pharmaceuticals, Inc. (OMED)'s Stem Cell Drugs, Deal Is Potentially Worth $3.3 Billion; OMED Stock Up 97.86% at Market Close (December 3, 2013) 12/4/2013  More...
immatics biotechnologies GmbH, Roche (RHHBY) Ink Cancer Pact Worth Up To $1 Billion 11/13/2013  More...
Shire To Pay $4.2 Billion For Rare Disease Firm ViroPharma Incorporated (VPHM) 11/11/2013  More...
ImmunoGen, Inc. (IMGN) Is On A Roll, Inks Fifth New License Agreement Of 2013 11/11/2013  More...
Salix Pharmaceuticals, Ltd. (SLXP) Bags Santarus Inc. (SNTS) for $2.6 Billion to Beef Up Gastro Drug Line-Up 11/8/2013  More...
Roche (RHHBY) to Pay Polyphor Up to $548 Million for Superbug Antibiotic 11/4/2013  More...
Startup NextCODE Health, Launches Operations With $15 Million in Venture Financing 10/23/2013  More...
Amgen (AMGN) Acquires Filgrastim Franchise Rights From Roche (RHHBY) in 100 Markets 10/23/2013  More...
PDL BioPharma, Inc. (PDLI) Snatches Up Depomed, Inc. (DEPO)'s Diabetes Portfolio for $240.5 Million 10/22/2013  More...
AmpliPhi Biosciences (TGEN) Signs Exclusive License With University of Leicester, UK to Develop Bacteriophage Therapies 10/17/2013  More...
AstraZeneca PLC (AZN)'s MedImmune (AZN) Takes Over Spirogen Ltd. for Up to $400 Million to Bolster Oncolology Portfolio 10/15/2013  More...
Ablynx (ABLYF) Scores $840 Million Inflammatory Drug Pact With AbbVie (ABBV); Ablynx Stock Rises 24.73% at Market Close (September 23, 2013) 9/23/2013  More...
Clovis Oncology (CLVS) Looking to Sell Itself 9/18/2013  More...
Roche (RHHBY), Inovio Pharmaceuticals (INO) Strike Vaccines Pact Worth $422.5 Million 9/11/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Makes $100 Million Upfront Payment in R&D Neurological Disorders Pact With Isis Pharmaceuticals, Inc. (ISIS) 9/9/2013  More...
Japan's Otsuka Pharmaceutical Co., Ltd. Shells Out $886 Million for U.S. Cancer Firm Astex Pharmaceuticals (ASTX) 9/5/2013  More...
Amgen (AMGN) Finally Reaches Deal to Buy Onyx Pharmaceuticals, Inc. (ONXX) for $10.4 Billion, AMGN Stock Rockets +7.72% on Monday @ Market Close (August 26, 2013) 8/26/2013  More...
Adimab LLC. Adds Celgene Corporation (CELG) to Its Growing List of Big-Name Drugmaking Partners 8/20/2013  More...
Shire plc Hires Adviser on Takeover Threat 8/20/2013  More...
Array BioPharma, Inc. (ARRY) Says Amgen (AMGN) Ends Agreement, to Cut 20 Percent of Jobs 8/9/2013  More...
Jazz Pharmaceuticals plc (JAZZ) and Alkermes plc (ALKS) are Seen as Next Targets Amid Irish Deal Frenzy: Real M&A 8/6/2013  More...
Transition Therapeutics Inc. (TTH.TO) Buys Rights to Eli Lilly and Company (LLY)'s Arthritis Drug; Transition May be Eligible for $130 Million+ 7/24/2013  More...
Pfizer Inc. (PFE) Not Moving Forward With Onyx Pharmaceuticals, Inc. (ONXX) Bid: Sources 7/19/2013  More...
Quest Diagnostics Inc. (DGX) Sells Ibrutinib Royalty Rights to Royalty Pharma for $485 Million in Cash 7/18/2013  More...
Spectrum Pharmaceuticals, Inc. (SPPI) Snaps Up Talon Therapeutics, Inc. (TLON.OB) in $206.3 Million Deal 7/17/2013  More...
Array BioPharma, Inc. (ARRY), Loxo Oncology Strike $434 Million+ Cancer Pact 7/11/2013  More...
AstraZeneca PLC (AZN) and NGM Biopharmaceuticals, Inc. Form Diabetes/Obesity Partnership 6/17/2013  More...
Johnson & Johnson (JNJ) to Buy Aragon Pharmaceuticals, Inc. for Up to $1 Billion 6/17/2013  More...
Johnson & Johnson (JNJ) Sells Final Stake in Elan Corporation PLC (ELN) for $332 Million 6/14/2013  More...
Cytokinetics, Inc. (CYTK), Amgen (AMGN) Expand $75 Million Development Deal Into Japan 6/12/2013  More...
AstraZeneca PLC (AZN) in Deal for Pearl Therapeutics Worth Up to $1.15 Billion 6/11/2013  More...
Actavis (ACT) Nabs Warner Chilcott, PLC (WCRX) for $8.5 Billion 5/20/2013  More...
AbbVie (ABBV), Galapagos NV (GLPG.BR) Ink $50 Million Crohn's Disease Pact 5/17/2013  More...
AstraZeneca PLC (AZN), Cubist Pharmaceuticals, Inc. (CBST), Astellas Pharma Inc. (YPH.BE) Said to Make Bids for Optimer Pharmaceuticals, Inc. (OPTR) 5/15/2013  More...
Elan Corporation PLC (ELN) Bets $1 Billion on Theravance, Inc. (THRX) Drugs; Move to Spurn Its Hostile Suitor? 5/13/2013  More...
Concert Pharmaceuticals, Inc. and Celgene Corporation (CELG) Tie the Knot in a $300 Million Tech Deal 5/6/2013  More...
Roche (RHHBY), Ascletis, Inc. to Collaborate on Hepatitis C Drugs for China 4/15/2013  More...
GlaxoSmithKline (GSK) Targets "Electroceuticals" for Potential New Therapies 4/11/2013  More...
GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical Engineering and Sciences to Develop New Medicines for Emerging Markets 4/9/2013  More...
Resverlogix Corporation (RVX.TO) to Spin-Out RVX Therapeutics Inc. (RVX) 4/8/2013  More...
Roche (RHHBY) and Isis Pharmaceuticals, Inc. (ISIS) Form $392 Million Alliance for Huntington's Disease 4/8/2013  More...
AstraZeneca PLC (AZN) Shells Out $240 Million Upfront for Moderna Therapeutics mRNA Drugs 3/22/2013  More...
bluebird bio Forms Cancer Drug Partnership With Celgene Corporation (CELG) 3/21/2013  More...
Receptos Licenses AbbVie (ABBV) Antibody for Co-Development 3/14/2013  More...
Astellas Pharma Inc. (YPH.BE) and Ambit Biosciences to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors 3/13/2013  More...
Presage Biosciences Snags $13 Million From Celgene Corporation (CELG) to Pick Winning Cancer Drug Combos 3/5/2013  More...
Roche (RHHBY) and Chiasma Inc. to Ally on Drug Development for Up to $600 Million 2/20/2013  More...
Merck & Co., Inc. (MRK) and Samsung Corporation to Develop Biosimilar Drugs Together 2/20/2013  More...
RQx Pharmaceuticals, Inc. Inks $111 Million Genentech (RHHBY) Deal 2/12/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) to Buy Elan Corporation PLC (ELN)'s Tysabri Rights for $3.25 Billion 2/7/2013  More...
The Medicines Company (MDCO) Buys Cholesterol Drug Rights From Alnylam Pharmaceuticals (ALNY) for Up to $205 Million 2/5/2013  More...
Allergan Inc. (AGN) to Buy MAP Pharmaceuticals, Inc. (MAPP) for $958 Million 1/23/2013  More...
Life Technologies (LIFE) Gains on Buyout Speculation 1/21/2013  More...
Shire plc Rises on AstraZeneca PLC (AZN) Bid Talk: Traders 1/17/2013  More...
Amgen (AMGN), BIND Biosciences, Inc. Ink $180 Million Tumor Treatment Deal 1/8/2013  More...
MacroGenics, Inc.'s DART Platform Grabs Potential $1 Billion Gilead Sciences, Inc. (GILD) Deal 1/8/2013  More...
Gilead Sciences, Inc. (GILD) Bags Blood Disorder Drug With $510 Million YM BioSciences (YM.TO) Buy 12/13/2012  More...
Amgen (AMGN) Bags Gene-Hunting Firm deCODE genetics, Inc. (DCGN) for $415 Million Cash 12/11/2012  More...
Teva Pharmaceutical Industries Limited (TEVA) Enters $376 Million Deal for Xenon Pharmaceuticals Inc. Pain Drug 12/11/2012  More...
Biogen Idec, Inc. (Massachusetts) (BIIB), Isis Pharmaceuticals, Inc. (ISIS) in Drug Development Pact for Up to $630 Million 12/10/2012  More...
Sanofi (France) (SAN.PA) Deal Could Net Selecta Biosciences, Inc. $900 Million 11/29/2012  More...
Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK) Team Up to Form Clinical Trial Site Database 11/15/2012  More...
Forest Laboratories, Inc. (FRX) and Adamas Pharmaceuticals Form Alliance for Up to $160 Million 11/14/2012  More...
Foundation Medicine and AstraZeneca PLC (AZN) Announce Genomic Profiling Collaboration 11/12/2012  More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) Shells Out $140 Million for Envoy Therapeutics 11/6/2012  More...
Amgen (AMGN) Closes Deal With Financial Firm to Open New Biotech Company Atara Biotherapeutics 10/29/2012  More...
Pfizer Inc. (PFE) Will Buy NextWave Pharmaceuticals for Up to $680 Million 10/23/2012  More...
Merck & Co., Inc. (MRK), AiCuris Ink $571 Million CMV Pact 10/16/2012  More...
Theravance, Inc. (THRX), Merck & Co., Inc. (MRK) Ink $153 Million Cardiovascular Pact 10/16/2012  More...
AstraZeneca PLC (AZN) Boosts Pipeline With $272 Million Ardelyx Inc. Drug Deal 10/9/2012  More...
Evotec AG (EVTG.F) and Bayer AG (BAY.F) Enter Into $765 Million Multi-Target Alliance to Fight Endometriosis 10/1/2012  More...
MacroGenics, Inc. Could Earn More Than $1 Billion Through New Servier Alliance 9/20/2012  More...
Baxter International, Inc. (BAX) and Onconova Therapeutics Inc. Announce European Licensing Agreement for Up to $515 Million 9/19/2012  More...
Complete Genomics, Inc. to be Bought by Chinese Firm for $117.6 Million 9/17/2012  More...
AstraZeneca PLC (AZN)'s MedImmune (AZN) Forms Chinese Joint Venture for Biologic Drug 9/11/2012  More...
Genmab A/S (GEN.CO) Inks $1.1 Billion Deal With Johnson & Johnson (JNJ) 8/31/2012  More...
Allergan Inc. (AGN), Molecular Partners AG Ink $1.5 Billion Exclusive Pact 8/21/2012  More...
AstraZeneca PLC (AZN) Buys Into Regulus Therapeutics, Inc.' MicroRNA Therapeutics for $28 Million 8/15/2012  More...
Elan Corporation PLC (ELN) Fuels Buyout Plans With $130 Million R&D Spinout, Unit Will Have Around 80 Staffers 8/14/2012  More...
S*Bio of Singapore Sells Cancer Drug Rights to MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) for $75 Million 8/10/2012  More...
GlaxoSmithKline (GSK) Completes $3.6 Billion Takeover of Human Genome Sciences, Inc. (HGSI) 8/6/2012  More...
Life Technologies (LIFE) Buys Navigenics for Genetic Diagnostics 7/17/2012  More...
GlaxoSmithKline (GSK) Clinches Deal to Buy Human Genome Sciences, Inc. (HGSI) for $2.8 Billion 7/16/2012  More...
Verastem, Inc. (VSTM) Buys Pfizer Inc. (PFE) Cancer Drug Candidate in Deal Worth $126.5 Million 7/12/2012  More...
Alnylam Pharmaceuticals (ALNY), Ascletis, Inc. Create Strategic Collaboration to Develop ALN-VSP 7/12/2012  More...
AstraZeneca PLC (AZN), Bristol-Myers Squibb Company (BMY) Join Forces in $7 Billion Deal for Amylin Pharmaceuticals, Inc. (AMLN) 7/3/2012  More...
Roche (RHHBY)'s Genentech (RHHBY) Grabs Alzheimer's Drug Rights From AC Immune SA for $418 Million-Plus 6/19/2012  More...
AstraZeneca PLC (AZN), Rigel Pharmaceuticals, Inc. (RIGL) Strike Potential $100 Million Asthma Drug Deal 6/19/2012  More...
GlaxoSmithKline (GSK) Rumored to be Buying $5 Billion BioMarin Pharmaceutical Inc. (BMRN) 6/13/2012  More...
GlaxoSmithKline (GSK) Pays $227 Million for Basilea Pharmaceutica (BSLN.SW) Eczema Drug 6/12/2012  More...
AstraZeneca PLC (AZN) Bids $4 Billion for Diabetes Specialist Amylin Pharmaceuticals, Inc. (AMLN) 6/5/2012  More...
Basilea Pharmaceutica (BSLN.SW) Participates in Public-private Collaboration to Tackle Antibiotic Resistance 5/25/2012  More...
Agilent Technologies Inc. (A) to Acquire Dako North America, Inc. for $2.2 Billion 5/17/2012  More...
GlaxoSmithKline (GSK)'s $2.6 Billion Bid for Human Genome Sciences, Inc. (HGSI) Goes Hostile 5/10/2012  More...
Novartis AG (NVS) Snags Fougera (AAA) for $1.5 Billion for Generic Skin Drugs 5/3/2012  More...
Axerion Therapeutics Inc., AstraZeneca PLC (AZN) Inks Pact to Combat Alzheimer's Disease 5/2/2012  More...
Amylin Pharmaceuticals, Inc. (AMLN) Explores Sale, Hires Bankers: Sources; Is AstraZeneca PLC (AZN) Interested? 4/24/2012  More...
AstraZeneca PLC (AZN) to Acquire Ardea Biosciences, Inc. for $1.26 Billion Including Lead Product Lesinurad in Phase III Development for Gout 4/23/2012  More...
Human Genome Sciences, Inc. (HGSI) Rejects GlaxoSmithKline (GSK)'s $2.6 Billion Bid, Seeks Higher Offers 4/20/2012  More...
Roche (RHHBY) Ready to Walk Away From $6.8 Billion Illumina, Inc. (ILMN) Bid 4/19/2012  More...
Amgen (AMGN) to Pay $315 Million for Privately-Held KAI Pharmaceuticals, Inc. 4/11/2012  More...
Watson Pharmaceuticals, Inc. (WPI) Close to $7 Billion Actavis Drug Deal: Sources 3/22/2012  More...
Heptares Grants Shire plc an Exclusive Worldwide $190 Million License to Develop and Commercialise Novel Drug Candidate for CNS Disorders 3/20/2012  More...
BioCon Limited (BIOCON.NS) Plunges After Pfizer Inc. (PFE) Scraps $350 Million Insulin Pact 3/14/2012  More...
EpiStem Ltd Announces a Three Year Collaboration With GlaxoSmithKline (GSK) in Fibrosis Research 3/13/2012  More...
Mersana Therapeutics, Inc. Strikes $270 Million Antibody-drug Conjugate Deal With Endo Pharmaceuticals (ENDP) 3/7/2012  More...
AngioChem, GlaxoSmithKline (GSK) Form $331 Million Pact to Discover and Develop Treatments of Lysosomal Storage Diseases 2/27/2012  More...
Enanta Pharmaceuticals, Inc. Strikes Hep C Drug Deal With Novartis AG (NVS) Worth Up to $440 Million 2/22/2012  More...
Pfizer Inc. (PFE) Eyes Tie-Ups With More Chinese Drugmakers; Will Ally With Zhejiang Hisun to Invest $545 Million in Generic Drug JV 2/21/2012  More...
Roche (RHHBY) Digs in for Long Fight as Illumina, Inc. (ILMN) Rejects $5.7 Billion Bid 2/10/2012  More...
Merck KGaA (MKGAF.PK) Signs $550 Million Cancer Pact With Threshold Pharmaceuticals, Inc. (THLD) 2/3/2012  More...
Genentech (RHHBY) Pours $95 Million into Constellation Pharmaceuticals Epigenetic Drug Platform, Deal Includes M&A Terms 1/17/2012  More...
Roche (RHHBY) Signs $646 Million Pain Pact With Xenon Pharmaceuticals Inc. 1/10/2012  More...
Bristol-Myers Squibb Company (BMY) to Acquire Inhibitex, Inc. (INHX) for $2.5 Billion 1/9/2012  More...
FORMA Therapeutics, Inc. Cuts $815 Million Deal With Boehringer Ingelheim Corporation to Discover Cancer Drugs 1/5/2012  More...
Alexion Pharmaceuticals Inc. (ALXN) to Pay $1 Billion for Enobia Pharma 12/29/2011  More...
Pharmacyclics, Inc. (PCYC) Could Get $975 Million in Johnson & Johnson (JNJ) License Deal 12/9/2011  More...
AstraZeneca PLC (AZN) Digs Deeper in China With Generics Buy 12/8/2011  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Teams With Samsung Corporation on $300 Million Biosimilar Venture 12/6/2011  More...
MacroGenics, Inc. Inks Pharma Deal With Servier Worth Up to $450 Million 12/1/2011  More...
Roche (RHHBY) and PTC Therapeutics, Inc. Sign $490 Million Deal for Genetic Disease Program 11/29/2011  More...
Gilead Sciences, Inc. (GILD) to Acquire Pharmasset, Inc. (VRUS) for $11 Billion 11/22/2011  More...
AMAG Pharmaceuticals, Inc. (AMAG) Hires Jefferies and Co. to Explore Sale 11/17/2011  More...
Gilead Sciences, Inc. (GILD) and Johnson & Johnson (JNJ)'s Tibotec Pharmaceuticals Ltd to Create Combination HIV Therapy 11/16/2011  More...
Lundbeck Inc. Pays Otsuka Pharmaceutical Co., Ltd. $200 Million Upfront in CNS Drug Deal, Complete Deal is Worth $1.8 Billion if Milestones are Met 11/14/2011  More...
Amylin Pharmaceuticals, Inc. (AMLN), Eli Lilly and Company (LLY) End Bydureon Pact; Amylin to Make $1.45 Billion in Payments 11/8/2011  More...
Abbott Laboratories (ABT) to Split Into 2 Companies 10/21/2011  More...
GlaxoSmithKline (GSK) May Make $4.8 Billion Bid for Human Genome Sciences, Inc. (HGSI): Source 10/19/2011  More...
Roche (RHHBY) Buys Anadys Pharmaceuticals, Inc. (ANDS) for $230 Million to Boost Hepatitis Ops 10/17/2011  More...
GlycoMimetics, Inc. Inks Licensing Deal Worth Up to $340 Million with Pfizer Inc. (PFE) 10/11/2011  More...
PPD, Inc. (PPDI) to be Acquired by The Carlyle Group and Hellman & Friedman for $3.9 Billion 10/4/2011  More...
Bristol-Myers Squibb Company (BMY) and Ambrx, Inc. Announce $24 Million Collaboration for Novel Biologics Programs in Diabetes and Heart Failure 9/22/2011  More...
Roche (RHHBY), Evotec AG (EVTG.F) Sign Alzheimer's Pact Worth Up to $830 Million 9/7/2011  More...
f-Star, Merck Serono Sign $708 Million Deal for Antibody-Derived Therapeutics 9/7/2011  More...
Astellas Pharma Inc. (YPH.BE), Evec Team Up for Antibody Pact Worth Up to $176.8 Million 9/6/2011  More...
Sanofi (France) (SASY.PA) Strikes Deal With Pfizer Inc. (PFE) to Make Generic Lipitor 9/1/2011  More...
Carlyle Group in Talks to Buy PPD, Inc. (PPDI) for as Much as $4.3 Billion 8/17/2011  More...
4-Antibody AG Forms Collaboration with Human Genome Sciences, Inc. (HGSI) 8/16/2011  More...
QIAGEN N.V. (QGEN) and Pfizer Inc. (PFE) Partner to Develop Companion Diagnostic for Novel Compound in Global Clinical Trials for Lung Cancer 8/16/2011  More...
AMAG Pharmaceuticals, Inc. (AMAG) Investor MSMB Makes $378 Million Takeover Bid for Firm to Stop Merger With Allos Therapeutics, Inc. (ALTH) 8/3/2011  More...
Bristol-Myers Squibb Company (BMY) to Pay Up to $475 Million for Amira Pharmaceuticals, Inc., Scoops Up Lung Drug 7/22/2011  More...
Novartis AG Ends Pursuit of Gen-Probe Incorporated (GPRO) 7/22/2011  More...
AMAG Pharmaceuticals, Inc. (AMAG), Allos Therapeutics, Inc. (ALTH) to Merge in $686 Million Deal 7/20/2011  More...
Micromet Inks Cancer Drug Deal With Amgen (AMGN) Worth Up to $1.01 Billion 7/12/2011  More...
Bristol-Myers Squibb Company (BMY), Innate Pharma (IPH.PA ) Announce $465 Million Deal for an Investigational Immuno-Oncology Biologic; Innate to Receive $35 Million Upfront, Shares Soar 7/7/2011  More...
Merck & Co., Inc. (MRK) Buys Hanwha Drug-Marketing Rights for $720 Million 6/13/2011  More...
Vertex Pharmaceuticals (MA) (VRTX) in Licensing Pact Potentially Worth $1.5 Billion With Alios BioPharma to Expand Hepatitis Pipeline 6/13/2011  More...
Merck & Co., Inc. (MRK), Roche (RHHBY) Pair Up on Tests for Cancer Treatments 6/7/2011  More...
Clovis Oncology (CLVS) Receives License for Worldwide Development and Commercialization Rights to Pfizer Inc. (PFE)'s Oral and IV PARP Inhibitor PF-01367338 6/3/2011  More...
AVEO Pharmaceuticals, Inc. (AVEO) Enters into Worldwide License Agreement with Centocor Ortho Biotech Products, L.P.; AVEO Receives $15 Million; Eligible for up to $540 Million 5/31/2011  More...
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Nails Nycomed Buyout for $13.7 Billion, Skin Unit to Spin Off 5/19/2011  More...
Allos Therapeutics, Inc. (ALTH) and Mundipharma AG Announce Strategic Collaboration for FOLOTYN; Allos to Receive $50 Million Upfront; Potentially up to $310.5 Million 5/11/2011  More...
Alkermes (ALKS), Elan Drug Technologies in $960 Million Merger 5/9/2011  More...
Teva Pharmaceutical Industries Limited (TEVA) to Buy Japanese Generic Drugmaker, Taiyo Pharmaceuticals Industry Co. Ltd. for $490 Million 5/3/2011  More...
Teva Pharmaceutical Industries Limited (TEVA) to Buy Cephalon, Inc. (CEPH) for Over $6 Billion, Tops Valeant Pharmaceuticals International (VRX) 5/2/2011  More...
Sanofi-Aventis (Canada) Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research 4/18/2011  More...
Exelixis, Inc. (EXEL) Said to Hire Goldman, Sachs & Co. to Field Possible Takeover Approaches; Shares Rise on Speculation 4/12/2011  More...
Zacharon Pharmaceuticals, Inc. Announces Potential $200 Million Collaboration With Pfizer Inc. (PFE) to Develop Drugs for Multiple Rare Disorders 4/7/2011  More...
Merck & Co., Inc. (MRK) to Acquire Inspiration Biopharmaceuticals for $430 Million 4/6/2011  More...
Cephalon, Inc. (CEPH) Spurns Valeant Pharmaceuticals International (VRX)'s $5.7 Billion Hostile Bid as Too Low 4/6/2011  More...
Cephalon, Inc. (CEPH) to Acquire Gemin X Pharmaceuticals, Inc. for $225 Million; up to $300 Million in Milestones 3/22/2011  More...
Seattle Genetics, Inc. (SGEN) Announces Antibody-Drug Conjugate Collaboration with Abbott Laboratories (ABT); Seattle Genetics Gets $8 Million Upfront; Eligible for as much as $200 Million 3/22/2011  More...
FivePrime Therapeutics, Inc. Nabs $495M Deal With Human Genome Sciences, Inc. (HGSI) to Develop Cancer Drug 3/17/2011  More...
Research Unit Going to China, Pfizer Inc. (PFE) Says; Company Plans Gradual Move of Antibacterials Operations to Shanghai 3/16/2011  More...
Daiichi Sankyo, Inc. (D4S.F) to Acquire Plexxikon Inc. for $805 Million Upfront, Approval of PLX4032 Could Bring in an Additional $130 Million 3/1/2011  More...
Astellas Pharma Inc. (YPH.BE) to Pay AVEO Pharmaceuticals, Inc. (AVEO) as Much as $1.3 Billion for Kidney Cancer Medicine; AVEO to Get $125M Upfront 2/17/2011  More...
Sanofi-Aventis (France) (SASY.PA) to Buy Genzyme Corporation (GENZ) for Over $20 Billion; Most Genzyme Jobs Safe 2/17/2011  More...
ADVENTRX Pharmaceuticals Inc. (ANX) Signs Definitive Agreement to Acquire SynthRx, Inc. 2/14/2011  More...
Danaher to Buy Beckman Coulter, Inc. (BEC) for $6.8 Billion 2/9/2011  More...
Optimer Pharmaceuticals, Inc. (OPTR), Astellas Pharma Inc. (YPH.BE) Sign Collaboration For Antibiotic Fidaxomicin; Optimer Eligible to Receive Milestone Payments of up to $224 Million Including $68 Million Upfront Cash Payment 2/7/2011  More...
Genoptix, Inc. Announces Agreement to be Acquired by Novartis Corporation (NVS) for $470 Million 1/25/2011  More...
Theraclone Sciences, Inc. and Pfizer Inc. (PFE) Enter into Infectious Disease and Cancer Antibody Discovery Collaboration; Pfizer to Pay up to $632M 1/19/2011  More...
Eli Lilly and Company (LLY) and Boehringer Ingelheim Corporation Announce Strategic Alliance to Bring New Diabetes Treatments to Patients Worldwide; Boehringer Ingelheim to Get 300M Euro; up to a Total of 625M Euro 1/12/2011  More...
Bristol-Myers Squibb Company (BMY) and Pharmasset, Inc. (VRUS) Enter into a Clinical Collaboration Agreement for Proof of Concept Combination Study in Patients Chronically Infected with Hepatitis C 1/10/2011  More...
Seattle Genetics, Inc. (SGEN), Pfizer Inc. (PFE) in $208 Million Antibody Tech Deal 1/7/2011  More...
As Deadline Nears, Suitor Genzyme Corporation (GENZ) May Have to Revise Bid For Sanofi-Aventis K.K. 12/10/2010  More...
Johnson & Johnson (JNJ) Launches $2.3 Billion Bid for Crucell N.V. (CRXL) 12/8/2010  More...
Dicerna Pharmaceuticals Expands Pact Kyowa Hakko Kirin; Original Agreement Worth $1.4 Billion Potentially 12/7/2010  More...
GE Healthcare and Johnson & Johnson (JNJ)'s Janssen Pharmaceutica N.V. Deal Pairs Two Alzheimer's Powerhouses 12/3/2010  More...
Merck & Co., Inc. (MRK) to Buy SmartCells, Inc. in Deal Worth Possibly $500 Million 12/2/2010  More...
GlaxoSmithKline (GSK) to Buy $129.4M in Theravance, Inc. (THRX) Stock 11/30/2010  More...





 

//-->